Olympus Corporation, Coloplast Corp and KARL STORZ SE & Co. KG are dominating the Global Flexible Digital Video Cystoscopes Market in the year 2018

Global flexible digital video cystoscopes market is expected to grow at a substantial CAGR of 5.3% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-flexible-digital-video-cystoscopes-market/

The flexible digital video cystoscopes market is a highly concentrated market which includes key players and local players. The market has witnessed various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to rising number of cystoscopes procedures such as bladder cancer, prostate cancer, urinary tract infection, rising prevalence of urological disorder, increasing geriatric population and improving healthcare infrastructure. The initiatives taken by the government to create awareness and healthcare programs which offers healthcare benefits which is also posing as an opportunity for the market.

The market has witness developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of innovative technology. For instance, In April 2017, Olympus Corporation acquired Image Stream Medical, Inc. a healthcare system integrator. This acquisition improves clinical outcomes, reduce cost and increase quality of life for patients. By this acquisition company strengthen its product portfolio and operation excellence.

Olympus Corporation dominated the flexible digital video cystoscopes market. The other key players existing in the market includes Coloplast Corp and KARL STORZ SE & Co. KG. The other key players existing in the market includes NeoScope Inc, Coloplast Group, Stryker, MOSS S.p.A, Richard Wolf GmbH, Endoservice GmbH, Maxer Endoscopy GmbH,   PENTAX Medical, OPTEC Endoscopy Systems GmbH, FUJIFILM Corporation, Boston Scientific Corporation, LABORIE, Zhuhai Mindhao Medical Co. ltd.

Olympus Corporation:

Olympus Corporation headquartered in Tokyo, Japan was founded in 1919. The company is engaged in research & development, manufacturing and marketing of medical device products. The company has four operating divisions’ medical, scientific solutions, imaging and others. The medical is market focused segment. Olympus Corporation product categories include medical systems, camera and audio, life sciences solution, industrial solution.

  • In April, 2017, Olympus Corporation acquired Image Stream Medical, Inc. a healthcare system integrator. This acquisition improves clinical outcomes, reduce cost and increase quality of life for patients. By this acquisition company strengthen its product portfolio and operation excellence.

The company has their presence in North America, Asia and Oceania, Europe, Japan. The company has various subsidiaries such as KeyMed (U.K.), Gyrus ACMI, Inc (U.S.), Olympus Corporation of the Americas(U.S.), Olympus New Zealand Limited (New Zealand)), Olympus Korea Co., Ltd. (Korea) among others.

Coloplast Corp:

Coloplast Corp headquartered Humlbaek, Denmark was founded in 1954. The company is focused in the development, manufacturing of ostomy care, continence care, wound & skin care and interventional urology products. The company operates through four business segments which include ostomy care, continence care, interventional urology, wound & skin care. The interventional urology segment is the market focused segment. The company has business presence in Europe, Americas, and Rest of the world.  

 It operates through its subsidiaries such as Comfort Medical, LLC (U.S.), Coloplast Ltd (China), Mpathy Medical Devices Limited (U.K), Home Supply + Care Beteiligungs GmbH (Germany), Laboratories Coloplast (France), Coloplast GmbH (Germany), SAS LILIAL (France).

KARL STORZ SE & Co. KG

KARL STORZ SE & Co. KG headquartered Tuttlinge, Germany was founded in 1945. The company is focused on the manufacturing and marketing of endoscopes and medical devices and instruments. The company operate their business in two product categories as human medicine, veterinary medicine.

  • In January, 2018, KARL STORZ SE & Co. KG established a joint venture with NDTec AG for strengthening its industrial endoscopy division.  By this joint venture, company enhances its product range for industrial use. KARL STORZ SE & Co. KG will earn -more than 75.00% of the new company KARL STORZ NDTec GmbH. KARL STORZ has contributed to the new company on the basis of international customer. This joint venture has a goal to combine the strengths and experiences of KARL STORZ as a global player with NDTec.

The company has global presence in America, Europe, Africa, Middle East, Asia and Australia. It operates through its subsidiaries such as KARL STORZ Endoscopy-America, Inc. (U.S), KARL STORZ Industrial-America, Inc. (U.S), KARL STORZ Endoscopy Canada Ltd (Canada), KARL STORZ Endoscopia México S.A. (Mexico), KARL STORZ Endoscopia Latin-America, Inc (Latin America), KARL STORZ Endoscopia (Cuba).